Stock Scorer

CONMED Corp (CNMD) · Insider trading

What CONMED's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$161,091
2 insiders, 100% under a plan
Net, 12 months
−$161,091
bought less sold
Latest filing
2026-09-10
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-02: $16,795 sold 2025-05: $227,760 sold 2025-07 2025-08: $31,365 sold 2025-09: $107,053 sold 2025-11: $161,091 sold 2026-01 2026-07
Bought Sold Largest month: $227,760

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Farkas CharlesDirector – $334,813 3 2025-09-12 15,756
Garner Todd WExecutive Vice President & CFO – $181,865 2 2025-11-06 1,836
Glaze RichardChief Information Officer – $27,386 2 2025-11-21 0

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2025-11-21 Glaze RichardChief Information Officer Saleplan 257 41.21 $10,591 0 Form 4
2025-11-06 Garner Todd WExecutive Vice President & CFO Saleplan 3,500 43.00 $150,500 1,836 Form 4
2025-09-12 Farkas CharlesDirector Sale 1,103 53.54 $59,055 15,756 Form 4
2025-09-12 Farkas CharlesDirector Sale 897 53.51 $47,998 14,859 Form 4
2025-08-07 Garner Todd WExecutive Vice President & CFO Sale 598 52.45 $31,365 0 Form 4
2025-05-05 Farkas CharlesDirector Sale 4,000 56.94 $227,760 16,346 Form 4
2025-02-11 Glaze RichardChief Information Officer Sale 257 65.35 $16,795 0 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

23 × option exercise9 × shares withheld for tax2 × other1 × grant or award
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-08 Kelderman KimDirector Option exercise M +500 – 500 Form 4
2026-06-02 Schwarzentraub Barbara JDirector Option exercise M +668 – 5,012 Form 4
2026-06-02 Kaye MarkDirector Option exercise M +668 – 820 Form 4
2026-06-02 Farkas CharlesDirector Option exercise M +668 – 15,527 Form 4
2026-06-02 Council LaVerne HDirector Option exercise M +668 – 4,716 Form 4
2026-06-02 Bronson David M.Director Option exercise M +668 – 17,909 Form 4
2026-03-06 Lalomia BrentExecutive VP RA, QA Option exercise M +75 – 941 Form 4
2026-03-06 Lalomia BrentExecutive VP RA, QA Shares withheld for tax F −26 39.90 915 Form 4
2026-02-24 Kaye MarkDirector Option exercise M +152 – 152 Form 4
2025-12-31 Lalomia BrentExecutive VP RA, QA Other J +32 40.60 125 Form 5
2025-11-20 Glaze RichardChief Information Officer Option exercise M +375 – 375 Form 4
2025-11-20 Glaze RichardChief Information Officer Shares withheld for tax F −118 40.63 257 Form 4
2025-11-04 Foust Hollie KGeneral Counsel & Corp Sec Option exercise M +4,000 – 4,000 Form 4
2025-11-04 Foust Hollie KGeneral Counsel & Corp Sec Shares withheld for tax F −1,114 45.71 2,886 Form 4
2025-10-31 Garner Todd WExecutive Vice President & CFO Option exercise M +7,500 – 7,500 Form 4
2025-10-31 Garner Todd WExecutive Vice President & CFO Shares withheld for tax F −2,164 44.00 5,336 Form 4
2025-06-03 Aronson Martha GoldbergDirector Option exercise M +479 – 12,391 Form 4
2025-06-03 Bronson David M.Director Option exercise M +479 – 17,241 Form 4
2025-06-03 Council LaVerne HDirector Option exercise M +479 – 4,048 Form 4
2025-06-03 Farkas CharlesDirector Option exercise M +479 – 16,859 Form 4
2025-06-03 Concannon BrianDirector Option exercise M +479 – 10,116 Form 4
2025-06-03 Schwarzentraub Barbara JDirector Option exercise M +479 – 4,344 Form 4
2025-05-29 Farkas CharlesDirector Option exercise M +1,000 55.70 17,346 Form 4
2025-05-29 Farkas CharlesDirector Shares withheld for tax F −966 57.69 16,380 Form 4
2025-05-20 Workman John LDirector Option exercise M +479 59.84 20,891 Form 4
2025-03-31 Garner Todd WExecutive Vice President & CFO Grant or award A +371 57.37 598 Form 4
2025-03-14 Shagory Peter KEVP, STRAT & CORP DEVT Option exercise M +4,500 55.42 8,213 Form 4
2025-03-14 Shagory Peter KEVP, STRAT & CORP DEVT Shares withheld for tax F −4,316 58.83 3,897 Form 4
2025-03-07 Lalomia BrentVice President QA and RA Option exercise M +75 – 1,032 Form 4
2025-03-07 Lalomia BrentVice President QA and RA Shares withheld for tax F −26 62.74 1,006 Form 4
2024-12-31 Lalomia BrentExecutive VP RA, QA Other J +23 68.44 94 Form 5
2024-11-20 Glaze RichardChief Information Officer Option exercise M +375 – 375 Form 4
2024-11-20 Glaze RichardChief Information Officer Shares withheld for tax F −118 70.69 257 Form 4
2024-11-07 Hartman Curt RDirector, President and CEO Option exercise M +30,000 51.30 34,299 Form 4
2024-11-07 Hartman Curt RDirector, President and CEO Shares withheld for tax F −24,303 74.76 9,996 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

CONMED's scores and multiples ›